Wednesday, 28 February 2018

Astra Spins Off Immune Drug Startup With Investors' $250 Million

AstraZeneca Plc is spinning off a company to develop drugs for immune disorders with as much as $250 million from a group of investors.

from Bloomberg http://ift.tt/2t9g2zF

No comments:

Post a Comment

America's homebuilding is powered by immigrant workers. Here are the places that rely on them the most.

The cities building the most homes rely more heavily on immigrant labor. Allen J. Schaben / Los Angeles Times The cities that build and...